338 related articles for article (PubMed ID: 34795260)
1. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
[TBL] [Abstract][Full Text] [Related]
2. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
[TBL] [Abstract][Full Text] [Related]
3. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
4. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
[TBL] [Abstract][Full Text] [Related]
5. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
[TBL] [Abstract][Full Text] [Related]
6. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
[TBL] [Abstract][Full Text] [Related]
7. Serine ADP-Ribosylation Depends on HPF1.
Bonfiglio JJ; Fontana P; Zhang Q; Colby T; Gibbs-Seymour I; Atanassov I; Bartlett E; Zaja R; Ahel I; Matic I
Mol Cell; 2017 Mar; 65(5):932-940.e6. PubMed ID: 28190768
[TBL] [Abstract][Full Text] [Related]
8. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
[TBL] [Abstract][Full Text] [Related]
9. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
Rudolph J; Roberts G; Muthurajan UM; Luger K
Elife; 2021 Mar; 10():. PubMed ID: 33683197
[TBL] [Abstract][Full Text] [Related]
10. Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.
Bilokapic S; Suskiewicz MJ; Ahel I; Halic M
Nature; 2020 Sep; 585(7826):609-613. PubMed ID: 32939087
[TBL] [Abstract][Full Text] [Related]
11. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
[TBL] [Abstract][Full Text] [Related]
12. Serine ADP-ribosylation reversal by the hydrolase ARH3.
Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
Elife; 2017 Jun; 6():. PubMed ID: 28650317
[TBL] [Abstract][Full Text] [Related]
13. PARP1/2 and Accessory Factor HPF1 Interlock to Form a Joint Active Site.
Cancer Discov; 2020 Apr; 10(4):486. PubMed ID: 32060056
[TBL] [Abstract][Full Text] [Related]
14. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.
Hendriks IA; Buch-Larsen SC; Prokhorova E; Elsborg JD; Rebak AKLFS; Zhu K; Ahel D; Lukas C; Ahel I; Nielsen ML
Nat Commun; 2021 Oct; 12(1):5893. PubMed ID: 34625544
[TBL] [Abstract][Full Text] [Related]
15. The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate.
Kurgina TA; Moor NA; Kutuzov MM; Lavrik OI
DNA Repair (Amst); 2022 Dec; 120():103423. PubMed ID: 36356486
[TBL] [Abstract][Full Text] [Related]
16. Serine is the major residue for ADP-ribosylation upon DNA damage.
Palazzo L; Leidecker O; Prokhorova E; Dauben H; Matic I; Ahel I
Elife; 2018 Feb; 7():. PubMed ID: 29480802
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
18. Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome.
Bacic L; Gaullier G; Sabantsev A; Lehmann LC; Brackmann K; Dimakou D; Halic M; Hewitt G; Boulton SJ; Deindl S
Elife; 2021 Sep; 10():. PubMed ID: 34486521
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site.
Leslie Pedrioli DM; Leutert M; Bilan V; Nowak K; Gunasekera K; Ferrari E; Imhof R; Malmström L; Hottiger MO
EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29954836
[TBL] [Abstract][Full Text] [Related]
20. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
Rudolph J; Roberts G; Luger K
Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]